ZA934110B - Diacylglycerol nicotinates, process fot their preparation and the pharmaceutical compositions which contain them - Google Patents

Diacylglycerol nicotinates, process fot their preparation and the pharmaceutical compositions which contain them

Info

Publication number
ZA934110B
ZA934110B ZA934110A ZA934110A ZA934110B ZA 934110 B ZA934110 B ZA 934110B ZA 934110 A ZA934110 A ZA 934110A ZA 934110 A ZA934110 A ZA 934110A ZA 934110 B ZA934110 B ZA 934110B
Authority
ZA
South Africa
Prior art keywords
nicotinates
diacylglycerol
contain
preparation
pharmaceutical compositions
Prior art date
Application number
ZA934110A
Other languages
English (en)
Inventor
Alex Cordi
Lean-Michel Lacoste
Jacques Duhault
Joseph Espinal
Michelle Boulanger
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA934110B publication Critical patent/ZA934110B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ZA934110A 1992-06-10 1993-06-10 Diacylglycerol nicotinates, process fot their preparation and the pharmaceutical compositions which contain them ZA934110B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR929206951A FR2692262B1 (fr) 1992-06-10 1992-06-10 Nouveaux nicotinates de diacylglycerols, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ZA934110B true ZA934110B (en) 1994-01-07

Family

ID=9430554

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934110A ZA934110B (en) 1992-06-10 1993-06-10 Diacylglycerol nicotinates, process fot their preparation and the pharmaceutical compositions which contain them

Country Status (12)

Country Link
US (1) US5385920A (de)
EP (1) EP0574312B1 (de)
JP (1) JPH07103106B2 (de)
AT (1) ATE112267T1 (de)
AU (1) AU657222B2 (de)
CA (1) CA2098069A1 (de)
DE (1) DE69300011T2 (de)
DK (1) DK0574312T3 (de)
ES (1) ES2065192T3 (de)
FR (1) FR2692262B1 (de)
NZ (1) NZ247820A (de)
ZA (1) ZA934110B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE40546E1 (en) * 1996-05-01 2008-10-21 Scarista, Ltd. 1,3-Propane diol esters and ethers and methods for their use in drug delivery
CA2220091C (en) * 1995-05-01 2011-01-04 Scotia Holdings Plc Nicotinic acid esters and pharmaceutical compositions containing them
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
WO2004101524A1 (en) * 2003-05-19 2004-11-25 Lonza Ag Polyglycerol esters of pyridinecarboxylic acids
EP3873415A1 (de) * 2018-11-02 2021-09-08 Unilever Global Ip Limited Bioenergetische nicotinsäureglycerinester, zusammensetzungen und verfahren zur verwendung davon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES488665A0 (es) * 1980-02-15 1980-12-16 Especialidades Farmaco Terape Procedimiento de obtencion de un nuevo compuesto antiateros-clerotico

Also Published As

Publication number Publication date
NZ247820A (en) 1994-10-26
FR2692262B1 (fr) 1994-08-05
ES2065192T3 (es) 1995-02-01
FR2692262A1 (fr) 1993-12-17
JPH07103106B2 (ja) 1995-11-08
EP0574312A1 (de) 1993-12-15
US5385920A (en) 1995-01-31
EP0574312B1 (de) 1994-09-28
AU657222B2 (en) 1995-03-02
AU4012393A (en) 1993-12-16
ATE112267T1 (de) 1994-10-15
DE69300011T2 (de) 1995-05-11
DE69300011D1 (de) 1994-11-03
CA2098069A1 (fr) 1993-12-10
DK0574312T3 (da) 1995-04-10
JPH0656786A (ja) 1994-03-01

Similar Documents

Publication Publication Date Title
AU663200B2 (en) New 3-(hydroxybenzylidenyl)-indolin-2-ones, processes for their preparation and pharmaceutical compositions containing them
GR3018212T3 (en) Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them.
HUT61564A (en) Process for producing erythromycin derivatives and pharmaceutical compositions comprising such active ingredient
IL107426A0 (en) Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same
NO942953L (no) 11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
GR3023936T3 (en) Heterocyclic alkylamides, process for their preparation and pharmaceutical compositions containing them
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
AU656466B2 (en) New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them
ZA936658B (en) Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them
HUT61004A (en) Process for producing quinoxaline derivatives and pharmaceutical compositions comprising such compounds as active ingredient
CA2003289A1 (en) Use of trifluoromethylphenyl-tetrahydropyridines for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders
IT1228288B (it) Composti ad attivita' antiserotoninica
HUT55385A (en) Process for producing 3-piperazinyl-benzazol derivatives and pharmaceutical compositions containing them as active components
HUT46664A (en) Process for producing new dihydropyridineamide derivatives and pharmaceutical compositions comprising these compounds
ZA944728B (en) alph -amino acid compounds a process for the preparation thereof and pharmaceutical compositions containing them
IL72330A (en) 3-alkyl-7-pyridyl-1h-triazolo(3,4-a)pyrimidine-5-one derivatives,their preparation and pharmaceutical compositions containing them
AU656674B2 (en) New thiochroman compounds, processes for the preparation thereof, and pharmaceutical compositions containing them
AU3559793A (en) New 3-aminochroman spiro compounds, processes for their preparation and pharmaceutical compositions containing them
AU4012393A (en) New diacylglycerol nicotinates, process for their preparation and pharmaceutical compositions which contain them
AU668398B2 (en) New aminoalkylchromones, processes for the preparation thereof, and pharmaceutical compositions containing them
CY2160B1 (en) Erburnane derivatives processes for their preparation and pharmaceutical compositions containing them
AU659738B2 (en) New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them
GR3021200T3 (en) (Cyclohexyl)-alken compounds, process for their preparation and pharmaceutical compositions containing them.
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.